SINGULAR HEALTH GROUP LTD — Capital/Financing Update 2021

Sep 30, 2021

==> picture [596 x 87] intentionally omitted <==

Singular Health Group Ltd: SHG

ASX Announcement

Singular Health Mandates PAC Partners as Corporate Advisor to Assist with Strategic Investments

1 October 2021 – Singular Health Group Ltd (ASX: SHG) (the “Company”), an Australianbased medical technology company, is pleased to announce the appointment of PAC Partners as corporate advisor to assist with the Company’s strategic investment strategy.

The fortuitous acquisition of the Virtual Surgical Planning software, approved by shareholders in May 2021, has accelerated the development of the Company’s Volumetric Rendering Platform and the Company’s mission to deliver better health outcomes through the design of patient-specific implants.

The ubiquitous nature of Singular Health’s core technology in being able to render any anatomical site captured by CT/MRI and/or PET scans into 3D & Virtual Reality provides an expansive range of potential clinical applications.

Ongoing travel restrictions, and the need to partner with specialist know-how, has led to the Company identifying strategic investments as being a capital efficient means by which to expand its geographic footprint, apply the core technology to specialist applications, and further accelerate the development of aspects of the Scan to Surgery[TM] initiative by investing in complementary technologies.

Commenting on the mandate, Thomas Hanly, Singular Health’s CEO, said: “PAC Partners, as the Lead Manager, were a key component in Singular Health’s highly successful Initial Public Offering earlier this year. Their experience in capital markets across medical, 3D printing, and imaging companies positions them well to assist Singular Health as we explore strategic investments to accelerate the commercialisation of our technology and fulfil our vision of developing better health literacy and delivering better health outcomes.”

The Mandate commences on the 1[st] of October 2021. The engagement with PAC Partners is for a period of 12 months for the provision of corporate and financial advisory services to the Company. The fee to be paid to PAC Partners is five (5) million transferable, unlisted options ($0.40, 3-year expiry from date of issue), to be issued following the announcement of a successful joint venture with / or acquisition of any prospective target company or six (6) months following the commencement of the Engagement, whichever comes sooner.

Authorised for release by the Board of Directors.

Ends

==> picture [596 x 88] intentionally omitted <==

==> picture [154 x 43] intentionally omitted <==

For further information contact

Investors	Corporate
James Hill +61 413 825 646 jhill@singular.health	Steven Wood Company Secretary + 61 8 9322 7600

About Singular Health:

Founded in 2017, Singular Health is a medical technology company that has developed and commercialised the proprietary Volumetric Rendering Platform (“VRP”) for the 3D & VR visualisation of anatomy using standard radiological imagery.

Singular Health is committed to developing technologies that provides patients and practitioners alike with access to personalised, enhanced medical data to inform better health decisions and is currently developing and deploying software products that are built upon the proprietary VRP on a global scale through a direct-to-consumer Software-as-aService (“SaaS”) model.

About Scan to Surgery:

Scan to Surgery[TM] is a disruptive technology driven process that revolutionises the planning and execution of surgical procedures, reducing cost and improving patient outcomes. Built on the backbone of our proprietary Medical File Transfer Protocol (MFTP), incorporating 3D/VR scan review with virtual surgical planning software and utilising local additive manufacturing facilities, Scan to Surgery[TM] aims to rapidly deliver patient-specific solutions.

==> picture [594 x 30] intentionally omitted <==

ASX: SHG | www.singular.health

2